Jennison Associates’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-58,139
| Closed | -$1.36M | – | 626 |
|
2021
Q4 | $1.36M | Sell |
58,139
-19,501
| -25% | -$455K | ﹤0.01% | 579 |
|
2021
Q3 | $1.29M | Buy |
+77,640
| New | +$1.29M | ﹤0.01% | 581 |
|
2021
Q1 | – | Sell |
-580,567
| Closed | -$31M | – | 660 |
|
2020
Q4 | $31M | Buy |
580,567
+428,136
| +281% | +$22.9M | 0.02% | 289 |
|
2020
Q3 | $6.29M | Buy |
152,431
+608
| +0.4% | +$25.1K | 0.01% | 416 |
|
2020
Q2 | $7.36M | Sell |
151,823
-15,404
| -9% | -$747K | 0.01% | 403 |
|
2020
Q1 | $7.07M | Buy |
167,227
+17,642
| +12% | +$745K | 0.01% | 368 |
|
2019
Q4 | $6.4M | Buy |
+149,585
| New | +$6.4M | 0.01% | 414 |
|
2017
Q1 | – | Sell |
-1,372,679
| Closed | -$39.6M | – | 632 |
|
2016
Q4 | $39.6M | Buy |
+1,372,679
| New | +$39.6M | 0.04% | 304 |
|
2016
Q2 | – | Sell |
-58,417
| Closed | -$1.63M | – | 619 |
|
2016
Q1 | $1.63M | Sell |
58,417
-534,789
| -90% | -$14.9M | ﹤0.01% | 534 |
|
2015
Q4 | $21.1M | Sell |
593,206
-504,158
| -46% | -$18M | 0.02% | 416 |
|
2015
Q3 | $36.3M | Sell |
1,097,364
-1,423,960
| -56% | -$47.1M | 0.04% | 351 |
|
2015
Q2 | $106M | Buy |
2,521,324
+40,103
| +2% | +$1.68M | 0.1% | 194 |
|
2015
Q1 | $80.9M | Sell |
2,481,221
-392,795
| -14% | -$12.8M | 0.07% | 245 |
|
2014
Q4 | $91.3M | Sell |
2,874,016
-29,473
| -1% | -$936K | 0.09% | 223 |
|
2014
Q3 | $71.9M | Sell |
2,903,489
-150,036
| -5% | -$3.71M | 0.07% | 257 |
|
2014
Q2 | $69M | Buy |
3,053,525
+4,108
| +0.1% | +$92.8K | 0.06% | 273 |
|
2014
Q1 | $74.2M | Buy |
3,049,417
+1,485,866
| +95% | +$36.2M | 0.07% | 252 |
|
2013
Q4 | $39.1M | Buy |
1,563,551
+50,359
| +3% | +$1.26M | 0.04% | 356 |
|
2013
Q3 | $41.6M | Sell |
1,513,192
-9,822
| -0.6% | -$270K | 0.04% | 331 |
|
2013
Q2 | $27.6M | Buy |
+1,523,014
| New | +$27.6M | 0.03% | 386 |
|